WATSON 3256 (Cyclobenzaprine 5 mg)
Pill imprint WATSON 3256 has been identified as Cyclobenzaprine hydrochloride 5 mg.
Cyclobenzaprine is used in the treatment of muscle spasm; sciatica; fibromyalgia; chronic myofascial pain; migraine (and more), and belongs to the drug class skeletal muscle relaxants. There is no proven risk in humans during pregnancy. Cyclobenzaprine 5 mg is not a controlled substance under the Controlled Substance Act (CSA).
- WATSON 3256
- 5 mg
- 8.00 mm
- Prescription only
- Drug Class:
- Skeletal muscle relaxants
- Pregnancy Category:
- B - No proven risk in humans
- CSA Schedule:
- Not a controlled drug
- Watson Pharmaceuticals
- National Drug Code (NDC):
- Inactive Ingredients:
- silicon dioxide
calcium phosphate dibasic anhydrous
hydroxypropyl cellulose (type h)
|NDC Code||Manufacturer / Repackager|
|21695-0036||Rebel Distributors Corp (repackager)|
|16590-0544||Stat RX USA LLC (repackager)|
|68071-0462||Nucare Pharmaceuticals Inc (repackager)|
|54868-5597||Physicians Total Care Inc (repackager)|
|33261-0377||Aidarex Pharmacuticals, LLC (repackager)|
|68258-7013||Dispensing Solutions Inc. (repackager)|
Note: Inactive ingredients may vary.
More about cyclobenzaprine
Related treatment guides
Every effort has been made to ensure that the information provided is accurate, up-to-date, and complete, but no guarantee is made to that effect. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Copyright 2016 Drugs.com, National Library of Medicine, Truven Health Analytics and Cerner Multum, Inc. All Rights Reserved.